BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20823704)

  • 21. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.
    Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M
    Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and function of the Lowe syndrome protein OCRL1.
    Lowe M
    Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OCRL mutation analysis in Italian patients with Lowe syndrome.
    Addis M; Loi M; Lepiani C; Cau M; Melis MA
    Hum Mutat; 2004 May; 23(5):524-5. PubMed ID: 15108291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antenatal diagnosis of Lowe syndrome.
    Sethi SK; Lunardi J; Kabra M; Deka D; Bagga A
    Clin Exp Nephrol; 2010 Jun; 14(3):296-7. PubMed ID: 20162319
    [No Abstract]   [Full Text] [Related]  

  • 25. Delayed vitreous haemorrhage after paediatric cataract surgery in Lowe syndrome.
    Mikhail M; Modabber M; Koenekoop RK; Braverman N; Khan A
    Eye (Lond); 2016 Sep; 30(9):1272-3. PubMed ID: 27229703
    [No Abstract]   [Full Text] [Related]  

  • 26. Ophthalmological finding in a patient with lowe syndrome.
    Tomčíková D; Gerinec A; Bzdúch V; Krásnik V; Bušányová B; Brennerová K
    Cesk Slov Oftalmol; 2018; 74(3):104-106. PubMed ID: 30650973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of Lowe syndrome presenting as increased fetal nuchal translucency.
    Lin SY; Lee CN; Shih JC; Lin CH; Su YN
    J Perinat Med; 2011 Jul; 39(4):483-5. PubMed ID: 21692684
    [No Abstract]   [Full Text] [Related]  

  • 28. Lowe syndrome with anal atresia: a possible variant of OCRL?
    Sönmez F; Temoçýn AK; Ozkan SB; Akçanal B; Karaman CZ; Türkmen M; Inan G
    Pediatr Int; 2003 Apr; 45(2):201-4. PubMed ID: 12709151
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lowe syndrome].
    Nakabayashi H
    Nihon Rinsho; 2006 Sep; Suppl 3():468-72. PubMed ID: 17022589
    [No Abstract]   [Full Text] [Related]  

  • 30. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lowe syndrome(oculocerebrorenal syndrome of Lowe; OCRL)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):489-90. PubMed ID: 11032004
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel OCRL1 gene mutations in six Chinese families with Lowe syndrome.
    Gao Y; Jiang F; Ou ZY
    World J Pediatr; 2016 Nov; 12(4):484-488. PubMed ID: 27059748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
    Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.
    Hichri H; Rendu J; Monnier N; Coutton C; Dorseuil O; Poussou RV; Baujat G; Blanchard A; Nobili F; Ranchin B; Remesy M; Salomon R; Satre V; Lunardi J
    Hum Mutat; 2011 Apr; 32(4):379-88. PubMed ID: 21031565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
    Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
    Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
    Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
    Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of two novel mutations in the OCRL1 gene in Japanese families with Lowe syndrome.
    Kubota T; Sakurai A; Arakawa K; Shimazu M; Wakui K; Furihata K; Fukushima Y
    Clin Genet; 1998 Sep; 54(3):199-202. PubMed ID: 9788721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging, magnetic resonance spectroscopy, and facial dysmorphism in a case of Lowe syndrome with novel OCRL1 gene mutation.
    Yuksel A; Karaca E; Albayram MS
    J Child Neurol; 2009 Jan; 24(1):93-6. PubMed ID: 19168822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Lowe syndrome: A particularly severe phenotype without clinical kidney involvement".
    Abdalla E; El-Beheiry A; Dieterich K; Thevenon J; Fauré J; Rendu J
    Am J Med Genet A; 2018 Feb; 176(2):460-464. PubMed ID: 29226564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.